#66FUZKK atlas leaders 1–100
Kilitch Drugs India Ltd
Maharashtra · Maharashtra / Mumbai–Pune
Sterile and injectable productsAPI / CDMO / synthesis
Manufacturing profile
Sterile and injectable products
API / CDMO / synthesis
State / territory: Maharashtra
Pharmaceutical cluster: Maharashtra / Mumbai–Pune
Selection basis
The company is placed in positions 1–100 as a major Indian manufacturer, exporter, API/CDMO, generics, vaccine or biopharma participant.
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Licence status, GMP status and the actual site portfolio must be rechecked through CDSCO and the relevant State Drug Controller.
Representative manufacturing and QC chain
- 1WFI, clean steam and cleanroom HVAC
- 2Solution preparation and bioburden control
- 3Sterile filtration
- 4Isolator/RABS filling or lyophilisation
- 5Sterility, endotoxin, particles and container-closure QC
- 6Route development, raw materials and scale-up
- 7Synthesis, fermentation or process development
- 8Purification, crystallisation, filtration and drying
- 9Technology transfer, cleaning and change control
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Sterility Test Membrane Filtration Quality CheckerBacterial Endotoxins LAL Quality CheckerParticle Count Injection USP <788> Quality CheckerFilter Integrity Test Quality CheckerPackage Integrity & Leak Test Quality CheckerOsmolality Quality CheckerEnvironmental Monitoring Cleanroom Quality CheckerAssay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality Checker
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Licence status, GMP status and the actual site portfolio must be rechecked through CDSCO and the relevant State Drug Controller.
Methodology